Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7429375
Reference Type
Journal Article
Title
Drug-induced acneiform eruption
Author(s)
Du-Thanh, A; Kluger, N; Bensalleh, H; Guillot, B; ,
Year
2011
Is Peer Reviewed?
Yes
Journal
American Journal of Clinical Dermatology
ISSN:
1175-0561
Publisher
ADIS INT LTD
Location
NORTHCOTE
Page Numbers
233-245
Language
English
PMID
21668032
DOI
10.2165/11588900-000000000-00000
Web of Science Id
WOS:000292588900002
URL
http://link.springer.com/10.2165/11588900-000000000-00000
Exit
Abstract
Drug-induced acne is a specific subset of acne that usually has some specific features, namely a monomorphic pattern, an unusual location of the lesions beyond the seborrheic areas, an unusual age of onset, a resistance to conventional acne therapy and, of course, the notion of a recent drug introduction. Many drugs can be responsible for such a clinical pattern. Corticosteroids, neuropsychotherapeutic drugs, antituberculosis drugs, and immunomodulating molecules are the more classical drugs associated with induced acne. Recently, new drugs, mainly targeted therapy in the field of oncology, such as epidermal growth factor receptor inhibitors, have been associated with an increased frequency of this adverse effect. Disruption of the culprit drug is rarely mandatory in cases of drug-induced acne. Close cooperation between the dermatologist and medical staff in charge of the patient is an important challenge to achieve optimal management of the initial disease.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity